The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Bi-Specific Antibodies Therapy Market Insights and Forecast to 2028

Global Bi-Specific Antibodies Therapy Market Insights and Forecast to 2028

Publishing Date : Jan, 2022

License Type :
 

Report Code : 1659237

No of Pages : 114

Ask Your Query
Synopsis
A bispecific antibody (BsAb), or specific monoclonal antibody (BsMAb) is an artificial protein comprised of fragments from two different antibodies. By virtue of the inclusion of two different antigen binding regions, a bispecific antibody is capable of recognizing and binding to two different antigens, or two different epitope on an antigen.
Market Analysis and Insights: Global Bi-Specific Antibodies Therapy Market
The global Bi-Specific Antibodies Therapy market size is projected to reach US$ 17140 million by 2028, from US$ 3266 million in 2021, at a CAGR of 26.4% during 2022-2028.
Global Bi-Specific Antibodies Therapy key players include Roche, Amgen, Sanofi, Pfizer, Johnson & Johnson, etc. Global top five manufacturers hold a share over 95%.
North America is the largest market, with a share about 65%, followed by Europe and China, both have a share over 30 percent. In terms of product, IgG-Based Antibodies is the largest segment, with a share over 85%. And in terms of application, the largest application is Haemophilia, followed by Cancer, etc.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bi-Specific Antibodies Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bi-Specific Antibodies Therapy market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bi-Specific Antibodies Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bi-Specific Antibodies Therapy market.
Global Bi-Specific Antibodies Therapy Scope and Market Size
Bi-Specific Antibodies Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Bi-Specific Antibodies Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Fragment-Based Antibodies
IgG-Based Antibodies
Segment by Application
Cancer
Haemophilia
Other Non-Cancer Diseases
By Company
Roche
Amgen
Sanofi
Pfizer
Johnson & Johnson
AstraZeneca
AbbVie
Lindis Biotech
MacroGenics, Inc
Genmab
Alphamab Co. Ltd
Akeso, Inc.
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Index
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bi-Specific Antibodies Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Fragment-Based Antibodies
1.2.3 IgG-Based Antibodies
1.3 Market by Application
1.3.1 Global Bi-Specific Antibodies Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 Haemophilia
1.3.4 Other Non-Cancer Diseases
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bi-Specific Antibodies Therapy Market Perspective (2017-2028)
2.2 Bi-Specific Antibodies Therapy Growth Trends by Region
2.2.1 Bi-Specific Antibodies Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Bi-Specific Antibodies Therapy Historic Market Size by Region (2017-2022)
2.2.3 Bi-Specific Antibodies Therapy Forecasted Market Size by Region (2023-2028)
2.3 Bi-Specific Antibodies Therapy Market Dynamics
2.3.1 Bi-Specific Antibodies Therapy Industry Trends
2.3.2 Bi-Specific Antibodies Therapy Market Drivers
2.3.3 Bi-Specific Antibodies Therapy Market Challenges
2.3.4 Bi-Specific Antibodies Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bi-Specific Antibodies Therapy Players by Revenue
3.1.1 Global Top Bi-Specific Antibodies Therapy Players by Revenue (2017-2022)
3.1.2 Global Bi-Specific Antibodies Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Bi-Specific Antibodies Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bi-Specific Antibodies Therapy Revenue
3.4 Global Bi-Specific Antibodies Therapy Market Concentration Ratio
3.4.1 Global Bi-Specific Antibodies Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bi-Specific Antibodies Therapy Revenue in 2021
3.5 Bi-Specific Antibodies Therapy Key Players Head office and Area Served
3.6 Key Players Bi-Specific Antibodies Therapy Product Solution and Service
3.7 Date of Enter into Bi-Specific Antibodies Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bi-Specific Antibodies Therapy Breakdown Data by Type
4.1 Global Bi-Specific Antibodies Therapy Historic Market Size by Type (2017-2022)
4.2 Global Bi-Specific Antibodies Therapy Forecasted Market Size by Type (2023-2028)
5 Bi-Specific Antibodies Therapy Breakdown Data by Application
5.1 Global Bi-Specific Antibodies Therapy Historic Market Size by Application (2017-2022)
5.2 Global Bi-Specific Antibodies Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Bi-Specific Antibodies Therapy Market Size (2017-2028)
6.2 North America Bi-Specific Antibodies Therapy Market Size by Type
6.2.1 North America Bi-Specific Antibodies Therapy Market Size by Type (2017-2022)
6.2.2 North America Bi-Specific Antibodies Therapy Market Size by Type (2023-2028)
6.2.3 North America Bi-Specific Antibodies Therapy Market Share by Type (2017-2028)
6.3 North America Bi-Specific Antibodies Therapy Market Size by Application
6.3.1 North America Bi-Specific Antibodies Therapy Market Size by Application (2017-2022)
6.3.2 North America Bi-Specific Antibodies Therapy Market Size by Application (2023-2028)
6.3.3 North America Bi-Specific Antibodies Therapy Market Share by Application (2017-2028)
6.4 North America Bi-Specific Antibodies Therapy Market Size by Country
6.4.1 North America Bi-Specific Antibodies Therapy Market Size by Country (2017-2022)
6.4.2 North America Bi-Specific Antibodies Therapy Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Bi-Specific Antibodies Therapy Market Size (2017-2028)
7.2 Europe Bi-Specific Antibodies Therapy Market Size by Type
7.2.1 Europe Bi-Specific Antibodies Therapy Market Size by Type (2017-2022)
7.2.2 Europe Bi-Specific Antibodies Therapy Market Size by Type (2023-2028)
7.2.3 Europe Bi-Specific Antibodies Therapy Market Share by Type (2017-2028)
7.3 Europe Bi-Specific Antibodies Therapy Market Size by Application
7.3.1 Europe Bi-Specific Antibodies Therapy Market Size by Application (2017-2022)
7.3.2 Europe Bi-Specific Antibodies Therapy Market Size by Application (2023-2028)
7.3.3 Europe Bi-Specific Antibodies Therapy Market Share by Application (2017-2028)
7.4 Europe Bi-Specific Antibodies Therapy Market Size by Country
7.4.1 Europe Bi-Specific Antibodies Therapy Market Size by Country (2017-2022)
7.4.2 Europe Bi-Specific Antibodies Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bi-Specific Antibodies Therapy Market Size (2017-2028)
8.2 Asia-Pacific Bi-Specific Antibodies Therapy Market Size by Type
8.2.1 Asia-Pacific Bi-Specific Antibodies Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Bi-Specific Antibodies Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Bi-Specific Antibodies Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Bi-Specific Antibodies Therapy Market Size by Application
8.3.1 Asia-Pacific Bi-Specific Antibodies Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Bi-Specific Antibodies Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Bi-Specific Antibodies Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Bi-Specific Antibodies Therapy Market Size by Region
8.4.1 Asia-Pacific Bi-Specific Antibodies Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Bi-Specific Antibodies Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Bi-Specific Antibodies Therapy Market Size (2017-2028)
9.2 Latin America Bi-Specific Antibodies Therapy Market Size by Type
9.2.1 Latin America Bi-Specific Antibodies Therapy Market Size by Type (2017-2022)
9.2.2 Latin America Bi-Specific Antibodies Therapy Market Size by Type (2023-2028)
9.2.3 Latin America Bi-Specific Antibodies Therapy Market Share by Type (2017-2028)
9.3 Latin America Bi-Specific Antibodies Therapy Market Size by Application
9.3.1 Latin America Bi-Specific Antibodies Therapy Market Size by Application (2017-2022)
9.3.2 Latin America Bi-Specific Antibodies Therapy Market Size by Application (2023-2028)
9.3.3 Latin America Bi-Specific Antibodies Therapy Market Share by Application (2017-2028)
9.4 Latin America Bi-Specific Antibodies Therapy Market Size by Country
9.4.1 Latin America Bi-Specific Antibodies Therapy Market Size by Country (2017-2022)
9.4.2 Latin America Bi-Specific Antibodies Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bi-Specific Antibodies Therapy Market Size (2017-2028)
10.2 Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Type
10.2.1 Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Bi-Specific Antibodies Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Application
10.3.1 Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Bi-Specific Antibodies Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Country
10.4.1 Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Bi-Specific Antibodies Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Bi-Specific Antibodies Therapy Introduction
11.1.4 Roche Revenue in Bi-Specific Antibodies Therapy Business (2017-2022)
11.1.5 Roche Recent Developments
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Bi-Specific Antibodies Therapy Introduction
11.2.4 Amgen Revenue in Bi-Specific Antibodies Therapy Business (2017-2022)
11.2.5 Amgen Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Bi-Specific Antibodies Therapy Introduction
11.3.4 Sanofi Revenue in Bi-Specific Antibodies Therapy Business (2017-2022)
11.3.5 Sanofi Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Bi-Specific Antibodies Therapy Introduction
11.4.4 Pfizer Revenue in Bi-Specific Antibodies Therapy Business (2017-2022)
11.4.5 Pfizer Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Bi-Specific Antibodies Therapy Introduction
11.5.4 Johnson & Johnson Revenue in Bi-Specific Antibodies Therapy Business (2017-2022)
11.5.5 Johnson & Johnson Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Bi-Specific Antibodies Therapy Introduction
11.6.4 AstraZeneca Revenue in Bi-Specific Antibodies Therapy Business (2017-2022)
11.6.5 AstraZeneca Recent Developments
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Bi-Specific Antibodies Therapy Introduction
11.7.4 AbbVie Revenue in Bi-Specific Antibodies Therapy Business (2017-2022)
11.7.5 AbbVie Recent Developments
11.8 Lindis Biotech
11.8.1 Lindis Biotech Company Details
11.8.2 Lindis Biotech Business Overview
11.8.3 Lindis Biotech Bi-Specific Antibodies Therapy Introduction
11.8.4 Lindis Biotech Revenue in Bi-Specific Antibodies Therapy Business (2017-2022)
11.8.5 Lindis Biotech Recent Developments
11.9 MacroGenics, Inc
11.9.1 MacroGenics, Inc Company Details
11.9.2 MacroGenics, Inc Business Overview
11.9.3 MacroGenics, Inc Bi-Specific Antibodies Therapy Introduction
11.9.4 MacroGenics, Inc Revenue in Bi-Specific Antibodies Therapy Business (2017-2022)
11.9.5 MacroGenics, Inc Recent Developments
11.10 Genmab
11.10.1 Genmab Company Details
11.10.2 Genmab Business Overview
11.10.3 Genmab Bi-Specific Antibodies Therapy Introduction
11.10.4 Genmab Revenue in Bi-Specific Antibodies Therapy Business (2017-2022)
11.10.5 Genmab Recent Developments
11.11 Alphamab Co. Ltd
11.11.1 Alphamab Co. Ltd Company Details
11.11.2 Alphamab Co. Ltd Business Overview
11.11.3 Alphamab Co. Ltd Bi-Specific Antibodies Therapy Introduction
11.11.4 Alphamab Co. Ltd Revenue in Bi-Specific Antibodies Therapy Business (2017-2022)
11.11.5 Alphamab Co. Ltd Recent Developments
11.12 Akeso, Inc.
11.12.1 Akeso, Inc. Company Details
11.12.2 Akeso, Inc. Business Overview
11.12.3 Akeso, Inc. Bi-Specific Antibodies Therapy Introduction
11.12.4 Akeso, Inc. Revenue in Bi-Specific Antibodies Therapy Business (2017-2022)
11.12.5 Akeso, Inc. Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
List of Tables
Table 1. Global Bi-Specific Antibodies Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Fragment-Based Antibodies
Table 3. Key Players of IgG-Based Antibodies
Table 4. Global Bi-Specific Antibodies Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Bi-Specific Antibodies Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Bi-Specific Antibodies Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Bi-Specific Antibodies Therapy Market Share by Region (2017-2022)
Table 8. Global Bi-Specific Antibodies Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Bi-Specific Antibodies Therapy Market Share by Region (2023-2028)
Table 10. Bi-Specific Antibodies Therapy Market Trends
Table 11. Bi-Specific Antibodies Therapy Market Drivers
Table 12. Bi-Specific Antibodies Therapy Market Challenges
Table 13. Bi-Specific Antibodies Therapy Market Restraints
Table 14. Global Bi-Specific Antibodies Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Bi-Specific Antibodies Therapy Revenue Share by Players (2017-2022)
Table 16. Global Top Bi-Specific Antibodies Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bi-Specific Antibodies Therapy as of 2021)
Table 17. Ranking of Global Top Bi-Specific Antibodies Therapy Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Bi-Specific Antibodies Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Bi-Specific Antibodies Therapy Product Solution and Service
Table 21. Date of Enter into Bi-Specific Antibodies Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Bi-Specific Antibodies Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Bi-Specific Antibodies Therapy Revenue Market Share by Type (2017-2022)
Table 25. Global Bi-Specific Antibodies Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Bi-Specific Antibodies Therapy Revenue Market Share by Type (2023-2028)
Table 27. Global Bi-Specific Antibodies Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Bi-Specific Antibodies Therapy Revenue Share by Application (2017-2022)
Table 29. Global Bi-Specific Antibodies Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Bi-Specific Antibodies Therapy Revenue Share by Application (2023-2028)
Table 31. North America Bi-Specific Antibodies Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Bi-Specific Antibodies Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Bi-Specific Antibodies Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Bi-Specific Antibodies Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Bi-Specific Antibodies Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Bi-Specific Antibodies Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Bi-Specific Antibodies Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Bi-Specific Antibodies Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Bi-Specific Antibodies Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Bi-Specific Antibodies Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Bi-Specific Antibodies Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Bi-Specific Antibodies Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Bi-Specific Antibodies Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Bi-Specific Antibodies Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Bi-Specific Antibodies Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Bi-Specific Antibodies Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Bi-Specific Antibodies Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Bi-Specific Antibodies Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Bi-Specific Antibodies Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Bi-Specific Antibodies Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Bi-Specific Antibodies Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Bi-Specific Antibodies Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Bi-Specific Antibodies Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Bi-Specific Antibodies Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Bi-Specific Antibodies Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Bi-Specific Antibodies Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Bi-Specific Antibodies Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Bi-Specific Antibodies Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Bi-Specific Antibodies Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Bi-Specific Antibodies Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 61. Roche Company Details
Table 62. Roche Business Overview
Table 63. Roche Bi-Specific Antibodies Therapy Product
Table 64. Roche Revenue in Bi-Specific Antibodies Therapy Business (2017-2022) & (US$ Million)
Table 65. Roche Recent Developments
Table 66. Amgen Company Details
Table 67. Amgen Business Overview
Table 68. Amgen Bi-Specific Antibodies Therapy Product
Table 69. Amgen Revenue in Bi-Specific Antibodies Therapy Business (2017-2022) & (US$ Million)
Table 70. Amgen Recent Developments
Table 71. Sanofi Company Details
Table 72. Sanofi Business Overview
Table 73. Sanofi Bi-Specific Antibodies Therapy Product
Table 74. Sanofi Revenue in Bi-Specific Antibodies Therapy Business (2017-2022) & (US$ Million)
Table 75. Sanofi Recent Developments
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Bi-Specific Antibodies Therapy Product
Table 79. Pfizer Revenue in Bi-Specific Antibodies Therapy Business (2017-2022) & (US$ Million)
Table 80. Pfizer Recent Developments
Table 81. Johnson & Johnson Company Details
Table 82. Johnson & Johnson Business Overview
Table 83. Johnson & Johnson Bi-Specific Antibodies Therapy Product
Table 84. Johnson & Johnson Revenue in Bi-Specific Antibodies Therapy Business (2017-2022) & (US$ Million)
Table 85. Johnson & Johnson Recent Developments
Table 86. AstraZeneca Company Details
Table 87. AstraZeneca Business Overview
Table 88. AstraZeneca Bi-Specific Antibodies Therapy Product
Table 89. AstraZeneca Revenue in Bi-Specific Antibodies Therapy Business (2017-2022) & (US$ Million)
Table 90. AstraZeneca Recent Developments
Table 91. AbbVie Company Details
Table 92. AbbVie Business Overview
Table 93. AbbVie Bi-Specific Antibodies Therapy Product
Table 94. AbbVie Revenue in Bi-Specific Antibodies Therapy Business (2017-2022) & (US$ Million)
Table 95. AbbVie Recent Developments
Table 96. Lindis Biotech Company Details
Table 97. Lindis Biotech Business Overview
Table 98. Lindis Biotech Bi-Specific Antibodies Therapy Product
Table 99. Lindis Biotech Revenue in Bi-Specific Antibodies Therapy Business (2017-2022) & (US$ Million)
Table 100. Lindis Biotech Recent Developments
Table 101. MacroGenics, Inc Company Details
Table 102. MacroGenics, Inc Business Overview
Table 103. MacroGenics, Inc Bi-Specific Antibodies Therapy Product
Table 104. MacroGenics, Inc Revenue in Bi-Specific Antibodies Therapy Business (2017-2022) & (US$ Million)
Table 105. MacroGenics, Inc Recent Developments
Table 106. Genmab Company Details
Table 107. Genmab Business Overview
Table 108. Genmab Bi-Specific Antibodies Therapy Product
Table 109. Genmab Revenue in Bi-Specific Antibodies Therapy Business (2017-2022) & (US$ Million)
Table 110. Genmab Recent Developments
Table 111. Alphamab Co. Ltd Company Details
Table 112. Alphamab Co. Ltd Business Overview
Table 113. Alphamab Co. Ltd Bi-Specific Antibodies Therapy Product
Table 114. Alphamab Co. Ltd Revenue in Bi-Specific Antibodies Therapy Business (2017-2022) & (US$ Million)
Table 115. Alphamab Co. Ltd Recent Developments
Table 116. Akeso, Inc. Company Details
Table 117. Akeso, Inc. Business Overview
Table 118. Akeso, Inc. Bi-Specific Antibodies Therapy Product
Table 119. Akeso, Inc. Revenue in Bi-Specific Antibodies Therapy Business (2017-2022) & (US$ Million)
Table 120. Akeso, Inc. Recent Developments
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bi-Specific Antibodies Therapy Market Share by Type: 2021 VS 2028
Figure 2. Fragment-Based Antibodies Features
Figure 3. IgG-Based Antibodies Features
Figure 4. Global Bi-Specific Antibodies Therapy Market Share by Application: 2021 VS 2028
Figure 5. Cancer Case Studies
Figure 6. Haemophilia Case Studies
Figure 7. Other Non-Cancer Diseases Case Studies
Figure 8. Bi-Specific Antibodies Therapy Report Years Considered
Figure 9. Global Bi-Specific Antibodies Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Bi-Specific Antibodies Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Bi-Specific Antibodies Therapy Market Share by Region: 2021 VS 2028
Figure 12. Global Bi-Specific Antibodies Therapy Market Share by Players in 2021
Figure 13. Global Top Bi-Specific Antibodies Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bi-Specific Antibodies Therapy as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Bi-Specific Antibodies Therapy Revenue in 2021
Figure 15. North America Bi-Specific Antibodies Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Bi-Specific Antibodies Therapy Market Size Market Share by Type (2017-2028)
Figure 17. North America Bi-Specific Antibodies Therapy Market Size Market Share by Application (2017-2028)
Figure 18. North America Bi-Specific Antibodies Therapy Market Size Share by Country (2017-2028)
Figure 19. United States Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Bi-Specific Antibodies Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Bi-Specific Antibodies Therapy Market Size Market Share by Type (2017-2028)
Figure 23. Europe Bi-Specific Antibodies Therapy Market Size Market Share by Application (2017-2028)
Figure 24. Europe Bi-Specific Antibodies Therapy Market Size Share by Country (2017-2028)
Figure 25. Germany Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Bi-Specific Antibodies Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Bi-Specific Antibodies Therapy Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Bi-Specific Antibodies Therapy Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Bi-Specific Antibodies Therapy Market Size Share by Region (2017-2028)
Figure 35. China Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Bi-Specific Antibodies Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Bi-Specific Antibodies Therapy Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Bi-Specific Antibodies Therapy Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Bi-Specific Antibodies Therapy Market Size Share by Country (2017-2028)
Figure 45. Mexico Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Bi-Specific Antibodies Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Bi-Specific Antibodies Therapy Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Bi-Specific Antibodies Therapy Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Bi-Specific Antibodies Therapy Market Size Share by Country (2017-2028)
Figure 51. Turkey Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Bi-Specific Antibodies Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Roche Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2017-2022)
Figure 55. Amgen Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2017-2022)
Figure 56. Sanofi Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2017-2022)
Figure 57. Pfizer Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2017-2022)
Figure 58. Johnson & Johnson Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2017-2022)
Figure 59. AstraZeneca Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2017-2022)
Figure 60. AbbVie Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2017-2022)
Figure 61. Lindis Biotech Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2017-2022)
Figure 62. MacroGenics, Inc Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2017-2022)
Figure 63. Genmab Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2017-2022)
Figure 64. Alphamab Co. Ltd Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2017-2022)
Figure 65. Akeso, Inc. Revenue Growth Rate in Bi-Specific Antibodies Therapy Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock